MannKind | MNKD - Equity Capital And Reserves

Stock Price
2.56
Daily Change
-0.05 -1.92%
Monthly
-53.79%
Yearly
-51.33%
Q1 Forecast
2.69

MannKind reported $-51.02M in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Adma Biologics USD 477.32M 46.13M Dec/2025
BioCryst Pharmaceuticals USD -119.15M 268.74M Dec/2025
Eli Lilly USD 26.54B 2.74B Dec/2025
Halozyme Therapeutics USD 48.81M 455.1M Dec/2025
Insmed USD 738.98M 206.6M Dec/2025
Karyopharm Therapeutics USD -269.26M 30.33M Sep/2025
MacroGenics USD 55.59M 11.41M Dec/2025
MannKind USD -51.02M 6.47M Dec/2025
Merck USD 51.85B 2.79B Sep/2025
Minerva Neurosciences USD -140.75M 106.17M Dec/2025
Novavax USD -127.75M 28.92M Dec/2025
Novo Nordisk DKK 26.56B 111.98B Jun/2025
Pfizer USD 92.8B 4.11B Sep/2025
Sanofi EUR 71.71B 1.55B Dec/2025
Xencor USD 635.59M 10.27M Dec/2025